Loading clinical trials...
Loading clinical trials...
The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department wi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Axis Shield Diagnostics Ltd
NCT06712641 · Sepsis
NCT07533994 · Sepsis
NCT07367113 · Sepsis, Septic Shock, and more
NCT07356583 · Enterovirus, Clinical Syndrome, and more
NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Cooper University Hospital
Camden, New Jersey
Universitetssjukhuset i Linkoping
Linköping
Skanes Universitetssjukhus i Lund
Lund
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions